Abstract:Patients with silicosis caused by occupational exposure to engineered stone (ES) present a rapid progression from simple silicosis (SS) to progressive massive fibrosis (PMF). Patient classification follows international rules based on radiology and high-resolution computed tomography (HRCT), but limited studies, if any, have explored biomarkers from routine clinical tests that can be used as predictors of disease status. Our objective was thus to investigate circulating biomarker levels and systemic inflammatory indices in ES silicosis patients whose exposure to ES dust ended several years ago. Ninety-one adult men, ex-workers in the manufacturing of ES, 53 diagnosed with SS and 38 with PMF, and 22 healthy male volunteers (HC) as controls not exposed to ES dust, were recruited. The following circulating levels of biomarkers like lactate dehydrogenase (LDH), angiotensin-converting-enzyme (ACE), protein C reactive (PCR), rheumatoid factor, alkaline phosphatase and fibrinogen were obtained from clinical reports after being measured from blood samples. As biochemical markers, only LDH (HC = 262 ± 48.1; SS = 315.4 ± 65.4; PMF = 337.6 ± 79.3 U/L), ACE (HC = 43.1 ± 18.4; SS = 78.2 ± 27.2; PMF = 86.1 ± 23.7 U/L) and fibrinogen (HC = 182.3 ± 49.1; SS = 212.2 ± 43.5; PMF = 256 ± 77.3 U/L) levels showed a significant sequential increase, not been observed for the rest of biomarkers, in the HC → SS → PMF direction. Moreover, several systemic inflammation indices neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic inflammation response index (SIRI), systemic immune-inflammation index (SII), aggregate index of systemic inflammation (AISI) derived from whole blood cell counts showed significant differences between the HC, SS and PMF groups. All these biomarkers were analyzed using receiver operating characteristic (ROC) curves, and the results provided moderately high sensitivity and specificity for discriminating between ES silicosis patient groups and healthy controls. Our study reveals that some inflammatory biomarkers, easily available from routine blood analysis, are present in ES silicosis patients even several years after cessation of exposure to ES silica dust and they could help to know the progression of the disease.

Quantitation of Silica Contents in Lung Explants of Transplanted Patients: Artificial Stone-Induced Silicosis vs. Idiopathic Pulmonary Fibrosis

Label-free Raman spectroscopy characterizes signatures of inflammation and fibrosis in the silicosis

Silicon, an important exposure marker in vivo in silicosis research

Exploratory study on noninvasive biomarker of silicosis in exhaled breath by solid-phase microextraction–gas chromatography–mass spectrometry analysis

Inflammatory indices obtained from routine blood tests show an inflammatory state associated with disease progression in engineered stone silicosis patients

Prevalence and risk factors for silicosis among a large cohort of stone benchtop industry workers

Elevated Serum S100A4 Levels in Patients with Silicosis

Functional, inflammatory and interstitial impairment due to artificial stone dust ultrafine particles exposure

Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis

Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China

Comparison Study Between Serum Level of Silicon and Transforming Growth Factor-Β1 and Tumor Necrosis Factor-Α

Differential immunological effects of silica nanoparticles on peripheral blood mononuclear cells of silicosis patients and controls

Determination of the Platelet Activating Factor in Silicotic Patients and Its Effect on Fibroblasts

Dynamic Changes of Surfactant Protein-D and Clara Cell Protein Expressions in Lung Tissue and Bronchoalveolar Lavage Fluid of Silica-Treated Rats

Analysis of Immune Cell Subsets in Peripheral Blood from Patients with Engineered Stone Silica-Induced Lung Inflammation

Exploration study on serum metabolic profiles of Chinese male patients with artificial stone silicosis, silicosis, and coal worker's pneumoconiosis

CC-Chemokine Ligand 18, CXC Motif Chemokine 13, and Osteopontin as Biomarkers of Silicosis and Asbestosis: A Case-Control Study

Screening of Serum Biomarkers and Establishment of a Decision Tree in Silica-Exposed Populations by Surface-Enhanced Laser Desorption Ionization Time-of-fly Mass Spectrometry.

Integrating routine blood biomarkers and artificial intelligence for supporting diagnosis of silicosis in engineered stone workers

Diagnostic performance of distinct metabolic features in the plasma of patients with silicosis

Significance of blood levels of silicon in early diagnosis of silicosis